Virological efficacy and safety of telaprevir-based triple therapy for chronic hepatitis C patients with advanced fibrosis
Not Applicable
- Conditions
- Chronic hepatitis C
- Registration Number
- JPRN-UMIN000011105
- Lead Sponsor
- The Kyushu University Liver Disease Study (KULDS) Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Not provided
Exclusion Criteria
Positivity for antibody to human immunodeficiency virus or positivity for hepatitis B surface antigen Hepatic decompensation (Child B or C) Excessive active alcohol consumption
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sustained virological response
- Secondary Outcome Measures
Name Time Method Predictors of SVR Adverse effects